AAAAAA
Results: 1-25/55
Authors:
Mann, DE
Gleason, SA
Kelly, PA
Easley, AR
Reiter, MJ
Citation: De. Mann et al., Incidence and management of prolonged charge times in the medtronic model 7219 implantable cardioverter defibrillator, J INTERV C, 5(2), 2001, pp. 189-191
Authors:
Kelly, PA
Finidori, J
Moulin, S
Kedzia, C
Binart, N
Citation: Pa. Kelly et al., Growth hormone receptor signalling and actions in bone growth, HORMONE RES, 55, 2001, pp. 14-17
Authors:
Kelly, PA
Binart, N
Freemark, M
Lucas, B
Goffin, V
Bouchard, B
Citation: Pa. Kelly et al., Prolactin receptor signal transduction pathways and actions determined in prolactin receptor knockout mice, BIOCH SOC T, 29, 2001, pp. 48-52
Authors:
Cooksy, LJ
Gill, P
Kelly, PA
Citation: Lj. Cooksy et al., The program logic model as an integrative framework for a multimethod evaluation, EVAL PROG P, 24(2), 2001, pp. 119-128
Authors:
McClellan, KA
Robertson, FG
Kindblom, J
Wennbo, H
Tornell, J
Bouchard, B
Kelly, PA
Ormandy, CJ
Citation: Ka. Mcclellan et al., Investigation of the role of prolactin in the development and function of the lacrimal and Harderian glands using genetically modified mice, INV OPHTH V, 42(1), 2001, pp. 23-30
Authors:
Kelly, PA
Binart, N
Lucas, B
Bouchard, B
Goffin, V
Citation: Pa. Kelly et al., Implications of multiple phenotypes observed in prolactin receptor knockout mice, FRONT NEURO, 22(2), 2001, pp. 140-145
Authors:
Yu, CC
Kelly, PA
Burckart, GJ
Zeevi, A
Citation: Cc. Yu et al., Sirolimus inhibition of lymphocyte proliferation is not antagonized by ciprofloxacin and other quinolone antibiotics, TRANSPLAN P, 33(6), 2001, pp. 2989-2991
Authors:
By, K
Kelly, PA
Kurth, MJ
Olmstead, MM
Nantz, MH
Citation: K. By et al., Synthesis of a C(4)-C(9) eleutheside template from D-glucal, TETRAHEDRON, 57(7), 2001, pp. 1183-1187
Authors:
Camarillo, IG
Thordarson, G
Moffat, JG
Van Horn, KM
Binart, N
Kelly, PA
Talamantes, F
Citation: Ig. Camarillo et al., Prolactin receptor expression in the epithelia and stroma of the rat mammary gland, J ENDOCR, 171(1), 2001, pp. 85-95
Authors:
Glasow, A
Horn, LC
Taymans, SE
Stratakis, CA
Kelly, PA
Kohler, U
Gillespie, J
Vonderhaar, BK
Bornstein, SR
Citation: A. Glasow et al., Mutational analysis of the PRL receptor gene in human breast tumors with differential PRL receptor protein expression, J CLIN END, 86(8), 2001, pp. 3826-3832
Authors:
Santos, CRA
Ingleton, PM
Cavaco, JEB
Kelly, PA
Edery, M
Power, DM
Citation: Cra. Santos et al., Cloning, characterization, and tissue distribution of prolactin receptor in the sea bream (Sparus aurata), GEN C ENDOC, 121(1), 2001, pp. 32-47
Authors:
Bernichtein, S
Kinet, S
Jeay, S
Llovera, M
Madern, D
Martial, JA
Kelly, PA
Goffin, V
Citation: S. Bernichtein et al., S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist, ENDOCRINOL, 142(9), 2001, pp. 3950-3963
Authors:
Baixeras, E
Jeay, S
Kelly, PA
Postel-Vinay, MC
Citation: E. Baixeras et al., The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the pro-B Ba/F3 cell line, ENDOCRINOL, 142(7), 2001, pp. 2968-2977
Authors:
Craven, AJ
Ormandy, CJ
Robertson, FG
Wilkins, RJ
Kelly, PA
Nixon, AJ
Pearson, AJ
Citation: Aj. Craven et al., Prolactin signaling influences the timing mechanism of the hair follicle: Analysis of hair growth cycles in prolactin receptor knockout mice, ENDOCRINOL, 142(6), 2001, pp. 2533-2539
Authors:
Freemark, M
Fleenor, D
Driscoll, P
Binart, N
Kelly, PA
Citation: M. Freemark et al., Body weight and fat deposition in prolactin receptor-deficient mice, ENDOCRINOL, 142(2), 2001, pp. 532-537
Authors:
Dif, F
Saunier, E
Demeneix, B
Kelly, PA
Edery, M
Citation: F. Dif et al., Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor, ENDOCRINOL, 142(12), 2001, pp. 5286-5293
Authors:
Jeay, S
Sonenshein, GE
Kelly, PA
Postel-Vinay, MC
Baixeras, E
Citation: S. Jeay et al., Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappa B and phosphatidylinositol 3-kinase, ENDOCRINOL, 142(1), 2001, pp. 147-156
Authors:
Gallego, MI
Binart, N
Robinson, GW
Okagaki, R
Coschigano, KT
Perry, J
Kopchick, JJ
Oka, T
Kelly, PA
Hennighausen, L
Citation: Mi. Gallego et al., Prolactin, growth hormone, and epidermal growth factor activate stat5 in different compartments of mammary tissue and exert different and overlappingdevelopmental effects, DEVELOP BIO, 229(1), 2001, pp. 163-175
Authors:
Ammarguellat, F
Llovera, M
Kelly, PA
Goffin, V
Citation: F. Ammarguellat et al., Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells, BIOC BIOP R, 284(4), 2001, pp. 1031-1038
Authors:
Binart, N
Kelly, PA
Citation: N. Binart et Pa. Kelly, Transgenic and knockout models of prolactin action in female reproduction, ENDOC UPD S, 13, 2001, pp. 123-141
Authors:
Llovera, M
Pichard, C
Bernichtein, S
Jeay, S
Touraine, P
Kelly, PA
Goffin, V
Citation: M. Llovera et al., Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation, ONCOGENE, 19(41), 2000, pp. 4695-4705
Authors:
Kahan, BD
Napoli, KL
Kelly, PA
Podbielski, J
Hussein, I
Urbauer, DL
Katz, SH
Van Buren, CT
Citation: Bd. Kahan et al., Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity, CLIN TRANSP, 14(2), 2000, pp. 97-109
Authors:
Favre-Young, H
Dif, F
Roussille, F
Demeneix, BA
Kelly, PA
Edery, M
de Luze, A
Citation: H. Favre-young et al., Cross-talk between signal transducer and activator of transcription (Stat5) and thyroid hormone receptor-beta 1 (TR beta 1) signaling pathways, MOL ENDOCR, 14(9), 2000, pp. 1411-1424
Authors:
Llovera, M
Touraine, P
Kelly, PA
Goffin, V
Citation: M. Llovera et al., Involvement of prolactin in breast cancer: redefining the molecular targets, EXP GERONT, 35(1), 2000, pp. 41-51
Authors:
Kelly, PA
Nowell, D
Citation: Pa. Kelly et D. Nowell, Three-dimensional cracks with Dugdale-type plastic zones, INT J FRACT, 106(4), 2000, pp. 291-309